In stent restenosis after percutaneous coronary interventionLetters to the EditorAnatol J Cardiol 2016; 16: 68-7473

References (5)

1. Jiang H, Liu W, Liu Y, Cao F. High levels of HB-EGF and interleukin-18 are associated with a high risk of in-stent restenosis. Anatol J Car-diol 2015; 15: 907-12
2. Hoffmann R, Mintz GS. Coronary in-stent restenosis - predictors, treatment and prevention. Eur Heart J 2000; 21: 1739-49
3. Yoshikawa M, Nakamura K, Nagase S, Sakuragi S, Kusano KF, Mat-subara H, et al. Effects of combined treatment with angiotensin II type 1 receptor blocker and statin on stent restenosis. J Cardiovasc Pharmacol 2009; 53: 179-86
4. Kamishirado H, Inoue T, Sakuma M, Tsuda T, Hayashi T, Takayanagi K, et al. Effects of statins on restenosis after coronary stent implan-tation. Angiology 2007; 58: 55-60
5. Lee HY, Kim JH, Kim BO, Byun YS, Cho S, Goh CW, et al. Regular exercise training reduces coronary restenosis after percutaneous coronary intervention in patients with acute myocardial infarction. Int J Cardiol 2013; 167: 2617-22